{"title":"Severe Alcohol-Related Liver Disease Following Bariatric Surgery.","authors":"Ahmed Ibrahim, Don C Rockey","doi":"10.1111/cob.70041","DOIUrl":null,"url":null,"abstract":"<p><p>Given the potential for more rapid ethanol absorption in patients who have undergone bariatric surgery, we hypothesized that bariatric surgery is associated with risk for more severe alcohol-related liver disease. Therefore, patients ≥ 18 years with alcohol use disorder (AUD) after bariatric surgery were examined using TriNetX (2010-2024). Propensity score matching (PSM) was used to compare patients with AUD following surgery to those with AUD without surgery. Primary outcomes included the likelihood of developing alcohol-associated hepatitis, cirrhosis, or any clinical decompensation event. All-cause mortality was a secondary outcome. Of 2 241 137 patients with AUD, 15 808 patients had AUD following bariatric surgery. Before PSM, patients undergoing surgery were generally older, predominantly female, with a higher body mass index (BMI) than those with AUD without surgery. After PSM, each cohort had 15 808 patients (mean [SD] age, 51 [13] years; 70% women). Patients with AUD following bariatric surgery had increased odds of acute alcohol-associated hepatitis (OR = 1.67, 95% CI: 1.51-1.85; p < 0.001), alcohol-associated cirrhosis (OR = 1.49, 95% CI: 1.37-1.52; p < 0.001), liver-related decompensation events (OR = 1.51, 95% CI: 1.39-1.64; p < 0.001) and all-cause mortality (OR = 1.13, 95% CI: 1.07-1.20; p < 0.001) than those with AUD without surgery. The data suggest an increased risk of severe alcohol-related liver disease in patients with AUD subsequent to bariatric surgery.</p>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":" ","pages":"e70041"},"PeriodicalIF":2.1000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Obesity","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/cob.70041","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Given the potential for more rapid ethanol absorption in patients who have undergone bariatric surgery, we hypothesized that bariatric surgery is associated with risk for more severe alcohol-related liver disease. Therefore, patients ≥ 18 years with alcohol use disorder (AUD) after bariatric surgery were examined using TriNetX (2010-2024). Propensity score matching (PSM) was used to compare patients with AUD following surgery to those with AUD without surgery. Primary outcomes included the likelihood of developing alcohol-associated hepatitis, cirrhosis, or any clinical decompensation event. All-cause mortality was a secondary outcome. Of 2 241 137 patients with AUD, 15 808 patients had AUD following bariatric surgery. Before PSM, patients undergoing surgery were generally older, predominantly female, with a higher body mass index (BMI) than those with AUD without surgery. After PSM, each cohort had 15 808 patients (mean [SD] age, 51 [13] years; 70% women). Patients with AUD following bariatric surgery had increased odds of acute alcohol-associated hepatitis (OR = 1.67, 95% CI: 1.51-1.85; p < 0.001), alcohol-associated cirrhosis (OR = 1.49, 95% CI: 1.37-1.52; p < 0.001), liver-related decompensation events (OR = 1.51, 95% CI: 1.39-1.64; p < 0.001) and all-cause mortality (OR = 1.13, 95% CI: 1.07-1.20; p < 0.001) than those with AUD without surgery. The data suggest an increased risk of severe alcohol-related liver disease in patients with AUD subsequent to bariatric surgery.
期刊介绍:
Clinical Obesity is an international peer-reviewed journal publishing high quality translational and clinical research papers and reviews focussing on obesity and its co-morbidities. Key areas of interest are: • Patient assessment, classification, diagnosis and prognosis • Drug treatments, clinical trials and supporting research • Bariatric surgery and follow-up issues • Surgical approaches to remove body fat • Pharmacological, dietary and behavioural approaches for weight loss • Clinical physiology • Clinically relevant epidemiology • Psychological aspects of obesity • Co-morbidities • Nursing and care of patients with obesity.